Clearsynth is a leading innovator in pharmaceutical reference standards, offering high-quality Reference Standards for Upadacitinib, including both pharmacopeial and non-pharmacopeial impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Our Upadacitinib impurity reference standards are invaluable for pharmaceutical research, supporting product development, ANDA and DMF submissions, quality control (QC), method validation, and stability studies. They also aid in identifying unknown impurities and assessing genotoxic potential.
Our Upadacitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Our Upadacitinib-related products undergo thorough characterization and are supplied with detailed Certificates of Analysis (COA) and analytical data that meet regulatory requirements. All supplied products are re-tested at regular intervals to ensure ongoing quality and compliance.
Upadacitinib Related Compounds
Stable Isotopes
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Upadacitinib D2 | Stable Isotopes | CS-O-41436 | 2768445-46-9 | Enquire |
| Upadacitinib-D2,15N | Stable Isotopes | CS-T-103804 | 1310726-60-3(unlabelled) | Enquire |
| Upadacitinib-d4 (major) | Stable Isotopes | CS-F-00244 | 1310726-60-3 (unlabelled) | In Stock |
API Standards
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Upadacitinib | API Standards | CS-T-87522 | 1310726-60-3 | Enquire |
| Upadacitinib Hydrate | API Standards | CS-ED-41494 | 2050057-56-0 | In Stock |
Impurities
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| 3-Tosyl Upadacitinib impurity | Impurities | CS-O-45305 | 1428243-28-0 | Enquire |
| N1-Methyl Upadacitinib impurity | Impurities | CS-O-45306 | Not Available | Enquire |
| N-Des-(2,2,2-trifluoroethyl) Upadacitinib | Impurities | CS-O-45302 | Not Available | Enquire |
| N-Methyl Upadacitinib | Impurities | CS-O-45308 | Not Available | Enquire |
| Upadacitinib 1-carboxamide Impurity | Impurities | CS-O-58935 | Not Available | Enquire |
| Upadacitinib 3-Hydroxy 4-N-oxide Impurity | Impurities | CS-O-58937 | Not Available | Enquire |
| Upadacitinib 3-Hydroxy 6-N-oxide Impurity | Impurities | CS-O-58938 | Not Available | Enquire |
| Upadacitinib 3-Hydroxy Impurity | Impurities | CS-O-58936 | Not Available | Enquire |
| Upadacitinib 6-N-Oxide Impurity | Impurities | CS-O-58934 | Not Available | Enquire |
| Upadacitinib Cyclized impurity | Impurities | CS-O-45312 | 1708997-42-5 | Enquire |
| Upadacitinib Des tosyl impurity | Impurities | CS-O-45313 | 1708997-43-6 | Enquire |
| Upadacitinib Di tosyl impurity | Impurities | CS-O-45311 | Not Available | Enquire |
| Upadacitinib di-formamyl Impurity | Impurities | CS-O-58939 | Not Available | Enquire |
| Upadacitinib Impurity 14 | Impurities | CS-EO-02331 | 2715120-86-6 | Enquire |
| Upadacitinib Impurity 3 | Impurities | CS-EO-01270 | 1310726-59-0 | In Stock |
| Upadacitinib Impurity 35 | Impurities | CS-P-09216 | Not Available | Enquire |
| Upadacitinib Impurity 4 | Impurities | CS-EO-01271 | Not Available | Enquire |
| Upadacitinib Impurity 5 | Impurities | CS-EO-01272 | Not Available | Enquire |
| Upadacitinib N-Formamyl Impurity | Impurities | CS-O-58940 | Not Available | Enquire |
| Upadacitinib TFEA Carbamate impurity | Impurities | CS-O-45309 | 2411540-30-0 | In Stock |
| Upadacitinib Trifluoroacetamide impurity | Impurities | CS-O-45310 | 2768445-19-6 | Enquire |
Intermediates
| COMPOUND | CATEGORY | CAT. No. | CAS. No. | STOCK STATUS |
|---|---|---|---|---|
| Upadacitinib tosylate intermediate | Intermediates | CS-O-58672 | 1869118-24-0 | Enquire |